Holen Sie sich die Stockscreener-App
41.00
2.86%
1.14
Handel nachbörslich:
41.00
Schlusskurs vom Vortag:
$39.86
Offen:
$40.34
24-Stunden-Volumen:
567.37K
Relative Volume:
0.85
Marktkapitalisierung:
$1.86B
Einnahmen:
$1.23B
Nettoeinkommen (Verlust:
$20.43M
KGV:
92.95
EPS:
0.4411
Netto-Cashflow:
$95.39M
1W Leistung:
-10.62%
1M Leistung:
+3.82%
6M Leistung:
-18.49%
1J Leistung:
+45.75%
1-Tages-Spanne:
$39.97
$41.10
1-Wochen-Bereich:
$39.13
$45.97
52-Wochen-Spanne:
$27.77
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, HQY, TEM, TXG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
41.00 | 1.86B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
TradingKey - TradingKey
OMCL|Omnicell Inc|Price:41.000|Chg%:+1.140 - TradingKey
Omnicell Inc (OMCL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Omnicell Inc (OMCL) Institutional Confidence - TradingKey
Omnicell Inc (OMCL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Omnicell Inc (OMCL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Omnicell Inc (OMCL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OMCL|Omnicell Inc|Price:39.845|Chg%:-1.015 - TradingKey
Price to earnings forward of Omnicell, Inc. – BX:OC9 - TradingView
Price to book forward of Omnicell, Inc. – NASDAQ:OMCL - TradingView
Omnicell Inc (OMCL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to book forward of Omnicell, Inc. – BX:OC9 - TradingView
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Omnicell (OMCL) Stock Forum and Discussion - Moomoo
Omnicell to report Q2 earnings: OmniSphere in focus - MSN
Omnicell to Report Q2 Earnings: OmniSphere in Focus - Yahoo Finance
(OMCL) Risk Channels and Responsive Allocation - Stock Traders Daily
1 Healthcare Stock to Target This Week and 2 We Brush Off - Yahoo Finance
Omnicell CEO Randall Lipps Executes Sale of 10,000 Shares Under Pre-Arranged Rule 10b5-1 Plan - Kalkine Media
Omnicell (OMCL) chief reports 10,000-share sale at $47 via trust - Stock Titan
ETFs Investing in Omnicell, Inc. Stocks - TradingView
Press Release: Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026 - 富途牛牛
Omnicell | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
OMNICELL, INC. SEC Filing (Jul 15, 2026) - Stock Titan
Does Omnicell’s ESOP Share Registration and Leadership Shift Reframe Its Capital Allocation Story (OMCL)? - simplywall.st
Omnicell (OMCL) up 0.1% since last earnings report: Can it continue? - MSN
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Omnicell (OMCL) - The Globe and Mail
Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026 - BioSpace
OMCL6251486 Bond Risk Profile - TradingView
OMCL6251486 Bond Profile — Key Metrics - TradingView
The Bull Case For Omnicell (OMCL) Could Change Following New President And ESOP Share Offering - Yahoo Finance
Omnicell to release Q2 2026 financial results on July 30 - scanx.trade
KeyBanc reiterates Omnicell stock rating on Titan XT launch By Investing.com - Investing.com South Africa
KeyBanc reiterates Omnicell stock rating on Titan XT launch - Investing.com
Should You Continue to Hold OMCL Stock in Your Portfolio Now? - TradingView
Fort Worth’s Omnicell Names Chief Operating Officer as President - Dallas Innovates
Enterprise value to revenue forward of Omnicell, Inc. – DUS:OC9 - TradingView
Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - AOL.com
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business - AOL.com
Omnicell (NASDAQ:OMCL) Leadership Move Puts Automation Back - Kalkine Media
What's Fueling Omnicell Stock's 52.6% Rally Over the Past Year? - Yahoo Finance Singapore
Omnicell focuses on automation and medication management as investors track long term opportunities - Ad Hoc News
Does Omnicell's (OMCL) Leadership Shift and Index Move Reframe Its Healthcare Automation Narrative? - simplywall.st
Omnicell Jumps 7.8% Amid Sector-Wide Rally - AlphaStreet
OMCLOmnicell Inc Options - Finviz
Form 4 Omnicell Inc For: 6 July By Investing.com - Investing.com Canada
Omnicell (NASDAQ: OMCL) President & COO awarded 12,309 RSUs in promotion grant - Stock Titan
Enterprise value to EBIT forward of Omnicell, Inc. – NASDAQ:OMCL - TradingView
OMCL News | OMNICELL INC (NASDAQ:OMCL) - ChartMill
Wells Fargo Maintains Omnicell(OMCL.US) With Buy Rating, Maintains Target Price $55 - Moomoo
Omnicell names Nnamdi Njoku as president - Medical Buyer
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.99%
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):